Achieve Life Sciences Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Good day, and welcome to the second annual Winter Wonderland Best Ideas Conference. The next presenting company is Achieve Life Sciences. (Operator Instructions) I'd now like to turn the floor over to today's host, John Bencich, CEO of Achieve Life Sciences. Sir, the floor is yours.
Great. Thanks for the introduction, and thanks to everyone for joining us today. Before we get going, I'd just like to remind everyone that I may be making forward-looking statements as part of the presentation today. So I would refer everyone to our filings on sec.gov and the risk factors contained therein.
So here in Achieve Life Science, we're focused on the development and ultimately, the commercialization of a drug called cytisinicline as an aid for smoking cessation and treatment for nicotine addiction. And we have a really compelling product on our hands since, one that has a huge amount of historical data supporting the safety and efficacy of the product. There's been extensive research as part of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsā 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |